Last 12 months
Inside the activity.
9 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 6 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2026 Filed Mar 18, 2026 20:45 UTC |
Adams Thomas EdwardChief Financial Officer
|
Exercise / conversionCommon Stock | 5,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000060 · form_4.xml · nonDerivative · entry 1 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:42 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 5,756 | $4.28 | $24,635.68 |
DisclosureSEC source: 0001161697-26-000058 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,212 F2 · kind: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:42 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 15,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000058 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting. Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 21:54 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 282,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000041 · form_4.xml · nonDerivative · entry 4 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 782,547 F3 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (3). Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 21:54 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000041 · form_4.xml · nonDerivative · entry 3 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners, LLC Disclosed balance after: 0 F2 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (2). F4 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (4). Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 21:54 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000041 · form_4.xml · nonDerivative · entry 2 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners, LLC Disclosed balance after: 750,000 F2 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (2). F4 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (4). Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 21:54 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 770,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000041 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 5,062,498 F1 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (1). F4 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (4). Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:51 UTC |
Matin ShahriarDirector
|
GrantCommon Stock | 2,581 | $5.81 | $14,995.61 |
DisclosureSEC source: 0001161697-26-000012 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,101 Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:51 UTC |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 2,581 | $5.81 | $14,995.61 |
DisclosureSEC source: 0001161697-26-000009 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,112 Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:51 UTC |
French DonnaDirector
|
GrantCommon Stock | 2,581 | $5.81 | $14,995.61 |
DisclosureSEC source: 0001161697-26-000011 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,471 Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:51 UTC |
WHOLIHAN EDWARDDirector
|
GrantCommon Stock | 2,581 | $5.81 | $14,995.61 |
DisclosureSEC source: 0001161697-26-000013 · form_4.xml · nonDerivative · entry 1 WHOLIHAN EDWARD · CIK 0001719764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,269 Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:51 UTC |
FLETCHER R JOHNDirector · Chairman of the Board
|
GrantCommon Stock | 3,872 | $5.81 | $22,496.32 |
DisclosureSEC source: 0001161697-26-000010 · form_4.xml · nonDerivative · entry 1 FLETCHER R JOHN · CIK 0001215024 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,592 Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:05 UTC |
Adams Thomas EdwardChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000018 · form_4.xml · derivative · entry 1 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit was issued pursuant to the Company's 2024 Omnibus Equity Incentive Plan and represents a contingent right to receive one share of common stock of KORU Medical Systems, Inc. (the "Company") upon vesting. F2 · derivative.exercise_date: One-fourth will vest on January 2, 2027 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. F2 · derivative.expiration_date: One-fourth will vest on January 2, 2027 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. Read SEC document |
| January 02, 2026 Filed Jan 16, 2026 00:46 UTC |
Schiller EricChief Technology Officer
|
GrantOption to buy Common Stock · Derivative | 232,297 | $0.00 Strike: $5.70 | $0.00 |
DisclosureSEC source: 0001161697-26-000035 · form_4.xml · derivative · entry 2 Schiller Eric · CIK 0002105459 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,297 Underlying: Common Stock · 232,297 shares Expires 2026-01-02 F2 · derivative.exercise_date: One-fourth will vest on January 2, 2027 and on each first, second and third anniversary thereof, subject to acceleration as provided in his employment agreement. Read SEC document |
| January 02, 2026 Filed Jan 16, 2026 00:46 UTC |
Schiller EricChief Technology Officer
|
GrantCommon Stock | 76,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000035 · form_4.xml · nonDerivative · entry 1 Schiller Eric · CIK 0002105459 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,426 F1 · shares: Represents shares of restricted stock issued as an employment inducement award that vest 25% annually commencing January 2, 2027, subject to acceleration as provided in his employment agreement. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:19 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
GiftCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000016 · form_4.xml · nonDerivative · entry 2 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,200 F3 · price: See Exhibit 99.1 to this Form 4 for explanation of note (3). Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:19 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
GrantCommon Stock | 2,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000016 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 5,832.916 F1 · price: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| November 26, 2025 Filed Nov 26, 2025 21:10 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 41,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000428 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 5,830,335 F1 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 20:09 UTC |
Tharby Linda MDirector · President and CEO
|
GrantCommon Stock | 29,463 | $4.08 | $120,209.04 |
DisclosureSEC source: 0001161697-25-000367 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,052,626 F1 · shares: 29,463 shares issued per her employment agreement for 2024 annual bonus earned, of which 70% was paid in cash and 30% paid in shares of common stock. F2 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; Includes 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| October 02, 2025 Filed Oct 2, 2025 20:41 UTC |
WHOLIHAN EDWARDDirector
|
GrantCommon Stock | 3,916 | $3.83 | $14,998.28 |
DisclosureSEC source: 0001161697-25-000340 · form_4.xml · nonDerivative · entry 1 WHOLIHAN EDWARD · CIK 0001719764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,688 Read SEC document |
| October 02, 2025 Filed Oct 2, 2025 20:39 UTC |
Matin ShahriarDirector
|
GrantCommon Stock | 3,916 | $3.83 | $14,998.28 |
DisclosureSEC source: 0001161697-25-000338 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,520 Read SEC document |
| October 02, 2025 Filed Oct 2, 2025 20:37 UTC |
French DonnaDirector
|
GrantCommon Stock | 3,916 | $3.83 | $14,998.28 |
DisclosureSEC source: 0001161697-25-000336 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,890 Read SEC document |
| October 02, 2025 Filed Oct 2, 2025 20:36 UTC |
FLETCHER R JOHNDirector · Chairman of the Board
|
GrantCommon Stock | 5,874 | $3.83 | $22,497.42 |
DisclosureSEC source: 0001161697-25-000334 · form_4.xml · nonDerivative · entry 1 FLETCHER R JOHN · CIK 0001215024 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,720 Read SEC document |
| October 02, 2025 Filed Oct 2, 2025 20:35 UTC |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 3,916 | $3.83 | $14,998.28 |
DisclosureSEC source: 0001161697-25-000332 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,531 Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:24 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
GrantCommon Stock | 3,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000330 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 5,871,335 F1 · price: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| August 01, 2025 Filed Aug 11, 2025 20:23 UTC |
KALBERMATTEN ADAM RChief Commercial Officer
|
GrantOption to buy Common Stock · Derivative | 600,000 | $0.00 Strike: $3.44 | $0.00 |
DisclosureSEC source: 0001161697-25-000245 · form_4.xml · derivative · entry 2 KALBERMATTEN ADAM R · CIK 0002080271 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2035-08-01 F2 · derivative.exercise_date: One-fourth will vest on August 1, 2026 and on each first, second and third anniversary thereof. Read SEC document |
| July 28, 2025 Filed Aug 11, 2025 20:23 UTC |
KALBERMATTEN ADAM RChief Commercial Officer
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000245 · form_4.xml · nonDerivative · entry 1 KALBERMATTEN ADAM R · CIK 0002080271 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 F1 · shares: Represents shares of restricted stock issued as an employment inducement award that vest 25% annually commencing July 28, 2026, subject to acceleration as provided in his employment agreement. Read SEC document |
| July 02, 2025 Filed Jul 2, 2025 21:17 UTC |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 4,189 | $3.58 | $14,996.62 |
DisclosureSEC source: 0001161697-25-000207 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,615 Read SEC document |
| July 02, 2025 Filed Jul 2, 2025 20:56 UTC |
WHOLIHAN EDWARDDirector
|
GrantCommon Stock | 4,189 | $3.58 | $14,996.62 |
DisclosureSEC source: 0001161697-25-000205 · form_4.xml · nonDerivative · entry 1 WHOLIHAN EDWARD · CIK 0001719764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,772 Read SEC document |
| July 02, 2025 Filed Jul 2, 2025 20:55 UTC |
Matin ShahriarDirector
|
GrantCommon Stock | 4,189 | $3.58 | $14,996.62 |
DisclosureSEC source: 0001161697-25-000203 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,604 Read SEC document |
| July 02, 2025 Filed Jul 2, 2025 20:53 UTC |
French DonnaDirector
|
GrantCommon Stock | 4,189 | $33.58 | $140,666.62 |
DisclosureSEC source: 0001161697-25-000201 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,974 Read SEC document |
| July 02, 2025 Filed Jul 2, 2025 20:50 UTC |
FLETCHER R JOHNDirector · Chairman of the Board
|
GrantCommon Stock | 6,284 | $3.58 | $22,496.72 |
DisclosureSEC source: 0001161697-25-000198 · form_4.xml · nonDerivative · entry 1 FLETCHER R JOHN · CIK 0001215024 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,846 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:30 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
GrantCommon Stock | 4,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000196 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 5,867,419 F1 · price: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:27 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 14,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000177 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 5,863,230 F1 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:25 UTC |
Pazdan ChristopherChief Operating Officer
|
GrantOption to buy Common Stock · Derivative | 36,077 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001161697-25-000248 · form_4.xml · derivative · entry 3 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,077 Underlying: Common Stock · 36,077 shares Expires 2035-05-12 F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F5 · derivative.exercise_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:25 UTC |
Pazdan ChristopherChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 21,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000248 · form_4.xml · derivative · entry 2 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,308 Underlying: Common Stock · 21,308 shares Expires not disclosed F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F4 · derivative.exercise_date: These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027 or upon an earlier change in control of the Company. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027. F4 · derivative.expiration_date: These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027 or upon an earlier change in control of the Company. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:25 UTC |
Pazdan ChristopherChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 21,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000248 · form_4.xml · derivative · entry 1 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,308 Underlying: Common Stock · 21,308 shares Expires not disclosed F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F3 · derivative.exercise_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier chance in control of the Company. F3 · derivative.expiration_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier chance in control of the Company. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:26 UTC |
Tharby Linda MDirector · President and CEO
|
GrantOption to buy Common Stock · Derivative | 94,772 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001161697-25-000250 · form_4.xml · derivative · entry 3 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,772 Underlying: Common Stock · 94,772 shares Expires 2035-05-12 F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F5 · derivative.exercise_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:26 UTC |
Tharby Linda MDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 111,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000250 · form_4.xml · derivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,729 Underlying: Common Stock · 111,729 shares Expires not disclosed F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F4 · derivative.exercise_date: These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027 or upon an earlier change in control of the Company. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027. F4 · derivative.expiration_date: These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027 or upon an earlier change in control of the Company. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:26 UTC |
Tharby Linda MDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 55,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000250 · form_4.xml · derivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,911 Underlying: Common Stock · 55,911 shares Expires not disclosed F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F3 · derivative.exercise_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. F3 · derivative.expiration_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:24 UTC |
Adams Thomas EdwardChief Financial Officer
|
GrantOption to buy Common Stock · Derivative | 55,583 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001161697-25-000246 · form_4.xml · derivative · entry 3 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,583 Underlying: Common Stock · 55,583 shares Expires 2035-05-12 F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F5 · derivative.exercise_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:24 UTC |
Adams Thomas EdwardChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 32,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000246 · form_4.xml · derivative · entry 2 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,773 Underlying: Common Stock · 32,773 shares Expires not disclosed F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F4 · derivative.exercise_date: These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027. F4 · derivative.expiration_date: These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:24 UTC |
Adams Thomas EdwardChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 32,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000246 · form_4.xml · derivative · entry 1 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,773 Underlying: Common Stock · 32,773 shares Expires not disclosed F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F3 · derivative.exercise_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier chance in control of the Company. F3 · derivative.expiration_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier chance in control of the Company. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:12 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 23,587 | $2.20 | $51,891.40 |
DisclosureSEC source: 0001161697-25-000148 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,023,163 F1 · kind: Represents shares withheld to satisfy tax obligations upon vesting of previously issued restricted stock. F2 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; Includes 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| April 02, 2025 Filed Apr 2, 2025 20:30 UTC |
WHOLIHAN EDWARDDirector
|
GrantCommon Stock | 5,870 | $2.56 | $15,027.20 |
DisclosureSEC source: 0001161697-25-000135 · form_4.xml · nonDerivative · entry 1 WHOLIHAN EDWARD · CIK 0001719764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,583 Read SEC document |
| April 02, 2025 Filed Apr 2, 2025 20:29 UTC |
French DonnaDirector
|
GrantCommon Stock | 5,870 | $2.56 | $15,027.20 |
DisclosureSEC source: 0001161697-25-000133 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,785 Read SEC document |
| April 02, 2025 Filed Apr 2, 2025 20:30 UTC |
Matin ShahriarDirector
|
GrantCommon Stock | 5,870 | $2.56 | $15,027.20 |
DisclosureSEC source: 0001161697-25-000134 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,415 Read SEC document |
| April 02, 2025 Filed Apr 2, 2025 20:29 UTC |
FLETCHER R JOHNDirector · Chairman of the Board
|
GrantCommon Stock | 8,806 | $2.56 | $22,543.36 |
DisclosureSEC source: 0001161697-25-000132 · form_4.xml · nonDerivative · entry 1 FLETCHER R JOHN · CIK 0001215024 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,562 Read SEC document |
| April 02, 2025 Filed Apr 2, 2025 20:29 UTC |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 5,870 | $2.56 | $15,027.20 |
DisclosureSEC source: 0001161697-25-000131 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,426 Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:02 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
GrantCommon Stock | 5,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000125 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 5,877,547 F1 · price: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.